Clinical trial

Effects of XOMA 052 on Insulin Production in Type 1 Diabetes

NCT01788033

Study summary

ClinicalTrials.gov

Effects of XOMA 052 on Insulin Production in Type 1 Diabetes

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention XOMA 052 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-09-01

PhasePHASE2

Conditions

Diabetes Mellitus Type 1unresolved

Interventions

XOMA 052DRUG

PlaceboDRUG

Sponsors & collaborators

University of Zurichlead sponsor

XOMA (US) LLCcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01788033 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.